相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
INZ
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
309271-94-1
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/50 mg/100 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1033.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥457.0 |
| 规格: | 5 mg | 产品价格: | ¥1000.0 |
| 规格: | 10 mg | 产品价格: | ¥1250.0 |
| 规格: | 50 mg | 产品价格: | ¥4500.0 |
| 规格: | 100 mg | 产品价格: | ¥6500.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Inauhzin
CAS No. : 309271-94-1
MCE 国际站:Inauhzin
产品活性:Inauhzin 是 SirT1/IMPDH2 的双重抑制剂,同时为 p53 的激活剂,可用于癌症研究。
研究领域:Cell Cycle/DNA Damage | Epigenetics | Apoptosis
In Vitro: Inauhzin (10 µM) induces p53 levels as effectively as actinomycin D (10 nM), and mediates p53-dependent cytotoxicity through its specific functional groups in human lung carcinoma H460 cells. Inauhzin (2 µM) induces p53 level and activity as well as p53-dependent apoptosis. Inauhzin also stabilizes p53 and inhibits its ubiquitylation. Inauhzin induces acetylation of p53 in H460 cells, but not tubulin, which is affected by knockdown of SIRT1. Inauhzin (0-2 µM) significantly enhances the expression level and activity of p53 in HCT116p53+/+ cells and enhances the expression level and activity of p53 in H460 cells in a dose-dependent manner. Inauhzin and Nutlin-3 demonstrate synergistic cytotoxicity in the Nutlin-3 low-sensitive cells. Inauhzin and Nutlin-3 synergistically induce p53-dependent apoptosis. Inauhzin targets both SirT1 and IMP dehydrogenase 2 (IMPDH2), and acts as a potent p53 activator.
In Vivo: Inauhzin (30 mg/kg, i.p.) effectively induces apoptosis and suppresses tumour growth of H460 xenograft harbouring p53. Inauhzin (30 mg/kg, i.p.) reduces the HCT116 tumor volume by appr 70%. Inauhzin (15 mg/kg) in combination with 150 mg/kg of Nutlin-3 demonstrates a significant synergy on p53 induction, apoptosis and tumor suppression of HCT116p53+/+ xenografts.
相关产品:Bioactive Compound Library Plus | Apoptosis Compound Library | Cell Cycle/DNA Damage Compound Library | Epigenetics Compound Library | Histone Modification Research Compound Library | Anti-Cancer Compound Library | Autophagy Compound Library | Anti-Aging Compound Library | Antioxidant Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Ferroptosis Compound Library | Pyroptosis Compound Library | Glutamine Metabolism Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Anti-Cancer Metabolism Compound Library | Transcription Factor-Targeted Library | Anti-Colorectal Cancer Compound Library | Highly Selective Inhibitors Library | Nicotinamide | Resveratrol | Selisistat | Nutlin-3a | Minocycline hydrochloride | 3-TYP | Nicotinamide riboside chloride | Pifithrin-α hydrobromide | GSK3326595 | Idasanutlin | Fisetin | Navtemadlin | Eprenetapopt | CBL0137 hydrochloride | OSS_128167 | Suramin sodium salt | MD-224 | SRT 1720 | Amifostine | UC2288 | Siremadlin | Pifithrin-α, p-Nitro, Cyclic | RG7112 | UBCS039 | Milademetan | NSC319726 | AGK2 | Sirtinol
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















